This morning a new batch of vaccines against COVID-19 of the laboratory Modernwhich will allow the vaccination process to continue at the national level.
As specified from the Ministry of Health It is a batch of 1,296,300 doses of the vaccine Modern, the first of this laboratory to arrive in our country. The KLM airline flight arrived at 11 in the morning at Jorge Chavez airport from Belgium.
The Deputy Minister of Public Health, Jorge Lopez Penaindicated that in the course of the week a total of 2,800,000 doses of the vaccine will arrive in the country. Modern.
“Today is a very special day because we are receiving one of the vaccines that have one of the most advanced studies,” he said from the air terminal.
He also explained that these doses of the Moderna’s vaccine they have an expiration term of 9 months, the longest period of validity among all the vaccines that have arrived in the country.
Dose Application
Meanwhile, the director of Strategic Interventions in Public Health of the Minsa, Alexis Holguinsaid that these Moderna vaccines have the approval of Digems to be applied to the population from 6 years. He added that the special groups to which the doses will be applied will be announced as previously.
The official recalled that Peru currently applies the third dose of the vaccine against COVID-19 to the population from 12 years of age.
“We must remember that there is already a special group, which are oncology and transplant patients, who have an approved protocol for four doses, and right now our technical areas are reviewing the protocol for a fourth dose in additional special groups,” he stressed.
He explained that the vaccine Modern it has an efficacy level greater than 90%, and that all the vaccines that have been applied in Peru have been approved by international health organizations.
“They are safe and they are effective. In the case of severe effects that have been reported in our country for almost a year, from February 2021 to February 2022, only 3 severe events have been reported, none of which led to death or sequelae, “he said.
The Minsa reported that, to date, Peru has received a total of 83,938,770 doses of the vaccine against COVID-19 of the laboratories Sinopharm, Pfizer (adult and pediatric) and AstraZeneca.
(With information from Andina)
–
